Veru Inc.
NASDAQ:VERUBiotechnology
+$0.13 today
- Market cap
- $50.72M
- Beta
- -1.13
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$0.65
Volume 0.34M
Average 1.82M
VERU EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Veru Inc.NASDAQ: VERU
EBITDA · Q2 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q2 FY2026 EBITDA was -$7.19M, compared with -$9.07M a year earlier. Trailing-twelve-month EBITDA was -$28.02M.
Context
- EBITDA grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of -$981.82K (+97.2%) for the fiscal year ending Sep 2026, a step up from the +2.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$7.19M-33.3% QoQ
- Last fiscal yearSep 2025
- -$35.38M+2.3% YoY
- LTMMar 2026
- -$28.02M+27.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +20.7% | +92.2% | +71.5 pp |
| 1 year | +2.3% | +97.2% | +95.0 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (35.38M) USD
- Year-over-year change
- +2.3%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | (35.38M) | +2.3% |
| FY2024 | 2024-09-30 | (36.2M) | +59.8% |
| FY2023 | 2023-09-30 | (89.98M) | -13.6% |
| FY2022 | 2022-09-30 | (79.23M) | -913.0% |
| FY2021 | 2021-09-30 | 9.75M | — |
EBITDA vs competitors
How VERU compares with its peers on the latest reported figures
- VERU's LTM Mar 2026 EBITDA of -$28.02M is the 4th highest of the 7 companies compared; the peer median is -$23.79M.
- Its year-over-year change of +27.0% is the highest of 7, against a peer median of -52.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | -$6.85M | -29.2% | — | 230.3% | |
| LTM Mar 2026 | -$12.27M | -63.0% | — | 823.9% | |
| LTM Mar 2026 | -$14.89M | -54.8% | — | — | |
| LTM Mar 2026 | -$28.02M | +27.0% | — | — | |
| LTM Mar 2026 | -$32.68M | -11.5% | — | — | |
| LTM Mar 2026 | -$40.92M | -50.5% | — | — | |
| LTM Dec 2025 | -$77.62M | -86.2% | — | 292.4% | |
| Peer median (excluding VERU) | -$23.79M | -52.7% | — | 292.4% | |
Competitors are the stored peer set for VERU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 61.26M | 39.35M | 16.3M | 16.89M | 0 |
| Cost of Revenue | 13.33M | 8.76M | 8.73M | 11.03M | 0 |
| Gross Profit | 47.93M | 30.59M | 7.57M | 5.85M | 0 |
| Gross Margin | 78.2% | 77.7% | 46.4% | 34.7% | — |
| Research & Development | 32.69M | 70.65M | 51.2M | 12.81M | 15.59M |
| Selling, General & Admin | 20.67M | 43.17M | 48.06M | 31.18M | 19.94M |
| Operating Expenses | 53.36M | 113.81M | 101.35M | 42.77M | 24.75M |
| Depreciation & Amortization | 593.87K | 209.6K | 269.87K | 268.18K | 152.11K |
| EBITDA | 9.75M | (79.23M) | (89.98M) | (36.2M) | (35.38M) |
| EBITDA Margin | 15.9% | -201.3% | -552.1% | -214.4% | — |
| Operating Income | 12.97M | (83.22M) | (93.78M) | (36.92M) | (24.75M) |
| Operating Margin | 21.2% | -211.5% | -575.5% | -218.6% | — |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.89M | 4.37M | 2.43M | 607.47K | 0 |
| Other Income / Expenses | (8.71M) | (580.66K) | 1.11M | (160.93K) | 9.07M |
| Income Before Tax | 4.27M | (83.8M) | (92.67M) | (37.08M) | (15.68M) |
| Pre-Tax Margin | 7.0% | -212.9% | -568.6% | -219.6% | — |
| Income Tax Expense | (3.13M) | 236.4K | 480.21K | 725.1K | 0 |
| Net Income | 7.39M | (83.78M) | (93.15M) | (37.8M) | (22.73M) |
| Net Margin | 12.1% | -212.9% | -571.6% | -223.9% | — |
| EPS (Basic) | 0.97 | (10.49) | (10.96) | (2.80) | (1.07) |
| EPS (Diluted) | 0.88 | (10.49) | (10.96) | (2.80) | (1.07) |
| Weighted Avg Shares | 7.63M | 8.01M | 8.5M | 13.49M | 14.65M |
| Weighted Avg Shares (Diluted) | 8.38M | 8.01M | 8.5M | 13.49M | 14.65M |
Veru Inc.
NASDAQ:VERU
Intrinsic Alpha fair value
Locked
Current Price
$3.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.